VivoSim Labs (VIVS) Net Income (2010 - 2026)
VivoSim Labs (VIVS) posted quarterly Net Income of -$3.2 million for Q1 2026, down 19.73% year-over-year from -$3.9 million in Q1 2025, and down 9.36% quarter-over-quarter from -$2.9 million in Q4 2025.
VivoSim Labs (VIVS) Net Income (2010 - 2026) Analysis & Trends
VivoSim Labs' Net Income history runs 17 years deep, the most recent figure standing at -$3.2 million for Q1 2026.
- In Q1 2026, Net Income fell 19.73% year-over-year to -$3.2 million; the TTM figure through Mar 2026 stood at -$11.7 million (up 5.84% YoY), while the FY2026 annual figure was -$14.2 million, up 6.97% from the prior year.
- Net Income for Q1 2026 stood at -$3.2 million, down from -$2.9 million in the prior quarter.
- The five-year high for Net Income was -$2.1 million in Q1 2022, with the low at -$7.5 million in Q1 2023.
- The 5-year median for Net Income is -$3.3 million (2022), against an average of -$3.4 million.
- The sharpest annual moves came in 2023 and 2024: Net Income sank 255.97% in 2023, then jumped 62.14% in 2024.
- VivoSim Labs' Net Income stood at -$3.3 million in 2022, then dropped by 13.86% to -$3.7 million in 2023, then gained by 4.24% to -$3.6 million in 2024, then increased by 19.21% to -$2.9 million in 2025, then fell by 9.36% to -$3.2 million in 2026.
- Business Quant data shows VIVS's Net Income at -$3.2 million in Q1 2026, -$2.9 million in Q4 2025, and -$2.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 482.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 164.49 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -355.03 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -13.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 81.49 Mn |
| 10 | VivoSim Labs | 1.49 Mn | 1.49 Mn | - | -2.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.06 Mn |
| Mar 31, 2026 | -3.16 Mn |
| Dec 31, 2025 | -2.89 Mn |
| Sep 30, 2025 | -2.68 Mn |
| Jun 30, 2025 | -2.97 Mn |
| Mar 31, 2025 | -2.64 Mn |
| Dec 31, 2024 | -3.57 Mn |
| Sep 30, 2024 | -2.74 Mn |
| Jun 30, 2024 | -3.47 Mn |
| Mar 31, 2024 | -2.82 Mn |
| Dec 31, 2023 | -3.73 Mn |
| Sep 30, 2023 | -4.12 Mn |
| Jun 30, 2023 | -4.17 Mn |
| Mar 31, 2023 | -7.45 Mn |
| Dec 31, 2022 | -3.28 Mn |
| Sep 30, 2022 | -3.48 Mn |
| Jun 30, 2022 | -3.33 Mn |
| Mar 31, 2022 | -2.09 Mn |
| Dec 31, 2021 | -4.03 Mn |
| Sep 30, 2021 | -3.51 Mn |